OTCMKTS:CPMV

Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

Mosaic ImmunoEngineering logo
$0.09 +0.01 (+11.97%)
As of 11/20/2026 02:03 PM Eastern

About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV)

Advanced

Key Stats

Today's Range
$0.08
▼
$0.09
50-Day Range
$0.06
▼
$0.33
52-Week Range
$0.05
▼
$0.75
Volume
12,041 shs
Average Volume
167 shs
Market Capitalization
$616.12 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mosaic ImmunoEngineering is a biotechnology company focused on developing immunotherapies for cancer. Its research centers on cowpea mosaic virus (CPMV), a plant virus being investigated as a way to stimulate immune responses against tumors.

The company’s approach involves using CPMV particles as an investigational, locally administered treatment intended to activate the body’s immune system in and around tumors. Mosaic’s work is centered on developing this technology for potential use against solid tumors; it is not an approved cancer treatment.

AI Generated. May Contain Errors.

Mosaic ImmunoEngineering Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

CPMV MarketRank™: 
0.7649122807 of 5 stars

Mosaic ImmunoEngineering scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mosaic ImmunoEngineering.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mosaic ImmunoEngineering is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mosaic ImmunoEngineering is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.04% of the float of Mosaic ImmunoEngineering has been sold short.
  • Short Interest Ratio / Days to Cover

    Mosaic ImmunoEngineering has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mosaic ImmunoEngineering has recently increased by 330.58%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Mosaic ImmunoEngineering does not currently pay a dividend.

  • Dividend Growth

    Mosaic ImmunoEngineering does not have a long track record of dividend growth.

  • News Sentiment

    Mosaic ImmunoEngineering has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Mosaic ImmunoEngineering this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mosaic ImmunoEngineering insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    80.99% of the stock of Mosaic ImmunoEngineering is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Mosaic ImmunoEngineering has minimal institutional ownership at this time.

  • Read more about Mosaic ImmunoEngineering's insider trading history.
Receive CPMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CPMV Stock News Headlines

Mosaic ImmunoEngineering Delays Annual 10-K Filing
ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
Mosaic ImmunoEngineering, Inc. (CPMV) - Yahoo Finance
Mosaic ImmunoEngineering, Inc. (CPMV)
Mosaic Co.
See More Headlines

CPMV Stock Analysis - Frequently Asked Questions

Mosaic ImmunoEngineering's stock was trading at $0.3110 on January 1st, 2026. Since then, CPMV shares have decreased by 72.6% and is now trading at $0.0851.

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) released its quarterly earnings data on Friday, November, 20th. The company reported ($0.02) earnings per share (EPS) for the quarter.

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/20/2026
Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:CPMV
CIK
836564
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$690 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-3,108.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.03) per share
Price / Book
-0.08

Miscellaneous

Outstanding Shares
7,240,000
Free Float
1,377,000
Market Cap
$616.12 thousand
Optionable
Not Optionable
Beta
-0.87
7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report

This page (OTCMKTS:CPMV) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners